167 related articles for article (PubMed ID: 31589865)
1. Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year after insertion: a systematic review and meta-analysis.
Maldonado LY; Sergison JE; Gao X; Hubacher D
Am J Obstet Gynecol; 2020 May; 222(5):451-468.e9. PubMed ID: 31589865
[TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis.
Sergison JE; Maldonado LY; Gao X; Hubacher D
Am J Obstet Gynecol; 2019 May; 220(5):440-448.e8. PubMed ID: 30527945
[TBL] [Abstract][Full Text] [Related]
3. Bleeding and spotting with the levonorgestrel 13.5 mg intrauterine system: the impact of insertion timing.
Shimoni N; Choudhury T; Goldman AR; Frondelli M; Chen PH
Contraception; 2019 Jun; 99(6):340-344. PubMed ID: 30831104
[TBL] [Abstract][Full Text] [Related]
4. The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Fels LM; Costescu D; Vieira CS; Peipert JF; Lukkari-Lax E; Hofmann BM; Reinecke I; Klein S; Wiesinger K; Lindenthal B; Speer R
Am J Obstet Gynecol; 2023 Mar; 228(3):322.e1-322.e15. PubMed ID: 36424684
[TBL] [Abstract][Full Text] [Related]
5. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
6. Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding.
Chen BA; Eisenberg DL; Schreiber CA; Turok DK; Olariu AI; Creinin MD
Am J Obstet Gynecol; 2020 Apr; 222(4S):S888.e1-S888.e6. PubMed ID: 31866516
[TBL] [Abstract][Full Text] [Related]
7. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
8. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
[TBL] [Abstract][Full Text] [Related]
9. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
10. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
[TBL] [Abstract][Full Text] [Related]
11. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
12. Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.
Sørdal T; Inki P; Draeby J; O'Flynn M; Schmelter T
Obstet Gynecol; 2013 May; 121(5):934-941. PubMed ID: 23635728
[TBL] [Abstract][Full Text] [Related]
13. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
14. Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial.
Jensen JT; Lukkari-Lax E; Schulze A; Wahdan Y; Serrani M; Kroll R
Am J Obstet Gynecol; 2022 Dec; 227(6):873.e1-873.e12. PubMed ID: 36096186
[TBL] [Abstract][Full Text] [Related]
15. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
16. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
[TBL] [Abstract][Full Text] [Related]
17. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Romero SA; Young K; Hickey M; Su HI
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial.
Cohen MA; Simmons KB; Edelman AB; Jensen JT
Contraception; 2019 Nov; 100(5):391-396. PubMed ID: 31226322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
